Dr Alexandre Akoulitchev obtained his PhD in cell biology from University College, London (with the research based at the Imperial Cancer Research Fund). He then spent six years at the Robert Wood Johnson Medical School-UMDNJ, NJ, as a research assistant funded by the Howard Hughes Medical Institute. Upon his return to England, he established his research laboratory at the Sir William Dunn School of Pathology, University of Oxford. He was a University Academic Fellow (Research Council UK) and a Senior Fellow of Exeter College, sponsored by Cancer Research UK, the Wellcome Trust, and The Medical Research Council. In 2008, he became Chief Scientific Officer of Oxford BioDynamics, a spin-out from his lab at the Dunn School of Pathology. The company specialises in developing diagnostic, prognostic, and predictive biomarkers for oncological, neurodegenerative, and inflammatory conditions.